Lipo C side effects are uncommon
Some people may experience mild symptoms occasionally, while others may have severe symptoms that occur more often
It's crucial for women with PCOS to work closely with their healthcare providers when considering GLP-1 treatments
Available from: Lin J, Pearson SA, Greenfield JR, Park KH, Havard A, Brieger D et al (2023) Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (20142022)
Tirzepatide is a GLP-1 and GIP receptor agonist approved by the FDA for type 2 diabetes and weight management, but it cannot be synthesized in a home kitchen or from natural ingredients
FDA Approval and History Phentermine has been approved by the FDA for short-term use as part of a weight loss program